MIRANDA BROWN: Open Payments
NPI 1194477182 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 19 payments from 14 companies in 2025. Trend: 2023 $400 · 2024 $428 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $32 |
| Organon LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novo Nordisk Inc | 2 | $29 |
| Abbott Laboratories | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: TZIELD, MOUNJARO, NEXPLANON, CAPLYTA, AIRSUPRA, Wegovy, FREESTYLE LIBRE 3, Veozah.
Industry payments across MI — which companies pay providers there.
